Silexion Therapeutics LTD Statistics Share Statistics Silexion Therapeutics LTD has n/a
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding n/a Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) n/a Shares Floating n/a Failed to Deliver (FTD) Shares 764 FTD / Avg. Volume 1.69%
Short Selling Information Short Interest n/a Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) n/a
Valuation Ratios PE Ratio n/a Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio -0.01 P/FCF Ratio n/a PEG Ratio undefined
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Silexion Therapeutics LTD.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.27,
with a Debt / Equity ratio of undefined.
Current Ratio 2.27 Quick Ratio 2.27 Debt / Equity n/a Debt / EBITDA n/a Debt / FCF n/a Interest Coverage undefined
Financial Efficiency Return on Equity is 0.32% and Return on Invested Capital is 39.63%.
Return on Equity 0.32% Return on Assets -0.94% Return on Invested Capital 39.63% Revenue Per Employee n/a Profits Per Employee n/a Employee Count undefined Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 32K Effective Tax Rate -0.01%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is -0.11, so Silexion Therapeutics LTD's
price volatility has been lower than the market average.
Beta -0.11 52-Week Price Change n/a 50-Day Moving Average 0.04 200-Day Moving Average n/a Relative Strength Index (RSI) 54.33 Average Volume (20 Days) 45,278
Income Statement
Revenue n/a Gross Profit n/a Operating Income -4.68M Net Income -4.94M EBITDA -4.64M EBIT n/a Earnings Per Share (EPS) 0.39
Full Income Statement Balance Sheet The company has 4.59M in cash and 171K in
debt, giving a net cash position of 4.42M.
Cash & Cash Equivalents 4.59M Total Debt 171K Net Cash 4.42M Retained Earnings -26.81M Total Assets 3.09M Working Capital -536K
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -4.53M
and capital expenditures -12K, giving a free cash flow of -4.54M.
Operating Cash Flow -4.53M Capital Expenditures -12K Free Cash Flow -4.54M FCF Per Share -6.67
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
